Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach

Steven W. Johnson; Shelby R. Ammirati; Charles E. Hartis; Stephen F. Weber; Michael R. Morgan; Timothy A. Darnell; Adwait Silwal; Holly N. Schmidlin; David H. Priest

doi:10.1016/j.ijantimicag.2017.01.016

Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach

Steven W. Johnson
, Shelby R. Ammirati
, Charles E. Hartis
, Stephen F. Weber
, Michael R. Morgan
, Timothy A. Darnell
, Adwait Silwal
, Holly N. Schmidlin
, David H. Priest

Campbell University

Department of Pharmacy
Novant Health-Forsyth Medical Center
Department of Pharmacy Practice
Campbell University
Infectious Disease Specialists

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	778-781
Number of pages	4
Journal	International Journal of Antimicrobial Agents
Volume	49
Issue number	6
DOIs	https://doi.org/10.1016/j.ijantimicag.2017.01.016
State	Published - Jun 1 2017

ASJC Scopus Subject Areas

Microbiology (medical)
Infectious Diseases
Pharmacology (medical)

Keywords

HCV
Hepatitis C virus
LDV/SOF
Ledipasvir/sofosbuvir
Real-life

Access to Document

10.1016/j.ijantimicag.2017.01.016

Cite this

Johnson, S. W., Ammirati, S. R., Hartis, C. E., Weber, S. F., Morgan, M. R., Darnell, T. A., Silwal, A., Schmidlin, H. N., & Priest, D. H. (2017). Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach. International Journal of Antimicrobial Agents, 49(6), 778-781. https://doi.org/10.1016/j.ijantimicag.2017.01.016

Johnson, SW, Ammirati, SR, Hartis, CE, Weber, SF, Morgan, MR, Darnell, TA, Silwal, A, Schmidlin, HN & Priest, DH 2017, 'Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach', International Journal of Antimicrobial Agents, vol. 49, no. 6, pp. 778-781. https://doi.org/10.1016/j.ijantimicag.2017.01.016

@article{45daa03fdb6f4221976e212464315239,

title = "Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach",

keywords = "HCV, Hepatitis C virus, LDV/SOF, Ledipasvir/sofosbuvir, Real-life",

author = "Johnson, \{Steven W.\} and Ammirati, \{Shelby R.\} and Hartis, \{Charles E.\} and Weber, \{Stephen F.\} and Morgan, \{Michael R.\} and Darnell, \{Timothy A.\} and Adwait Silwal and Schmidlin, \{Holly N.\} and Priest, \{David H.\}",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier B.V. and International Society of Chemotherapy",

year = "2017",

month = jun,

day = "1",

doi = "10.1016/j.ijantimicag.2017.01.016",

language = "English",

volume = "49",

pages = "778--781",

journal = "International Journal of Antimicrobial Agents",

issn = "0924-8579",

number = "6",

}

TY - JOUR

T1 - Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C

T2 - a collaborative treatment approach

AU - Johnson, Steven W.

AU - Ammirati, Shelby R.

AU - Hartis, Charles E.

AU - Weber, Stephen F.

AU - Morgan, Michael R.

AU - Darnell, Timothy A.

AU - Silwal, Adwait

AU - Schmidlin, Holly N.

AU - Priest, David H.

PY - 2017/6/1

Y1 - 2017/6/1

KW - HCV

KW - Hepatitis C virus

KW - LDV/SOF

KW - Ledipasvir/sofosbuvir

KW - Real-life

UR - https://www.scopus.com/pages/publications/85017438323

UR - https://www.scopus.com/pages/publications/85017438323#tab=citedBy

U2 - 10.1016/j.ijantimicag.2017.01.016

DO - 10.1016/j.ijantimicag.2017.01.016

M3 - Article

C2 - 28389353

AN - SCOPUS:85017438323

SN - 0924-8579

VL - 49

SP - 778

EP - 781

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

IS - 6

ER -

Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Cite this